“So we're definitely expecting to see significant synergy and efficiency coming from there.”

In context

“d what are essentially the investment priorities that you're continuing to channel OpEx all is towards? James Caci: Yes. So thanks, Gabriela. So in terms of our, kind of, let's call it, operating margin, the biggest contributors for us this year are going to be efficiencies both in sales and marketing and G&A. So this will be -- 2023 will be our first full year as a public company where we don't have any kind of hangover. If you think about last year, it was really our first full year, but the comparable from the prior year was only a partial year of being public. So again, we don't have the incremental going from '22 to '23 that we did going from '21 to '22. So we naturally have some efficiency on the G&A side just for some of the lack of being public first time. So that's helpful there. So we're definitely expecting to see significant synergy and efficiency coming from there. And the same thing on sales and marketing. We're seeing, again, where we're trying to be as efficient as possible as TJ alluded to, more heavy reliance on the channel is making us more efficient. So we're expecting to see -- those 2 things being the key driver. On the R&D side, we're continuing to make investments both in R&D development efforts in terms of figuring out our strategic objectives going forward. So we're continuing to invest heavily in R&D, and you won't really see a slowdown there going forward. again. So that's kind of where we're going to see it both sales and marketing and G&A. Gabriela Borges: That makes sense. I'll ask one more on the topic of R&D priorities, which is tell us a little bit more about what milestones we should look for this year outside of the Microsof”